Accuray reported $24.23M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.74B 14M
Accuray ARAY:US $ 24.23M 2.38M
Atricure ATRC:US $ 56.96M 7.75M
Boston Scientific BSX:US $ 1.12B 102M
Cardiovascular Systems CSII:US $ 45.71M 4.27M
Cryolife CRY:US $ 33.04M 313K
Edwards Lifesciences EW:US $ 374.5M 43.7M
Genmark Diagnostics GNMK:US $ 12.4M 2.06M
Hologic HOLX:US $ 260M 39.6M
Inogen INGN:US $ 34.54M 3.45M
Mesa Laboratories MLAB:US $ 16.28M 1.4M
Natus Medical BABY:US $ 42.1M 1.73M
Orthofix International OFIX:US $ 75.67M 8.44M
Oxford Immunotec Global OXFD:US 11.97M 934K
Surmodics SRDX:US $ 7.88M 22K
Tandem Diabetes Care TNDM:US $ 66.52M 7.96M
Trinity Biotech TRIB:US 6.59M 192K
Varian Medical Systems VAR:US $ 157.5M 17M